ERBB2 and breast carcinoma: For example, higher pCR rates were found in hormone receptor (HR)-negative tumors in multiple trials19–21, and a high Ki-67 index (≥50%) was observed to be an independent predictive factor for pCR in HER2-positive breast cancer patients22,23.